Cytokine modulation in sepsis and septic shock

Author： Zanotti Sergio Kumar Anand Kumar Aseem

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.8, 2002-08, pp. : 1061-1075

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sepsis and septic shock: inching forwards

By Cohen Jonathan

Clinical Medicine, Vol. 9, Iss. 3, 2009-06 ,pp. : 256-257

Royal College Of Physicians

Access to resources Recommend Favorite

Management of Sepsis and Septic Shock in Infants and Children

By Vonrosenstiel N.

Pediatric Drugs, Vol. 3, Iss. 1, 2001-01 ,pp. : 9-27

Adis International

Access to resources Recommend Favorite

The safety and efficacy of the use of vasopressin in sepsis and septic shock

By Wilson Stephen J Mehta Saurabh S Bellamy Mark C

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 1027-1039

Informa Healthcare

Access to resources Recommend Favorite

Anti-inflammatory therapies in sepsis and septic shock

By Freeman B.D. Natanson C.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1651-1663

Informa Healthcare

Access to resources Recommend Favorite

Experimental and emerging therapies for sepsis and septic shock

By Añel Ramon L Kumar Anand

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1471-1485

Informa Healthcare

Access to resources Recommend Favorite